Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.25.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share The following securities were not included diluted shares outstanding because the effect would be anti-dilutive (in shares).

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Warrants

 

 

 

4,405,220

 

 

 

4,720,645

 

 

 

4,514,503

 

 

 

4,726,518

 

Stock options

 

 

 

4,640,812

 

 

 

5,331,581

 

 

 

4,687,246

 

 

 

5,032,825

 

Convertible notes

 

 

 

238,601,424

 

 

 

102,954,830

 

 

 

243,360,690

 

 

 

102,954,830

 

Total anti-dilutive instrument

 

 

 

247,647,456

 

 

 

113,007,056

 

 

 

252,562,439

 

 

 

112,714,173